JPH04261122A - Angiotensinase activity inhibitor contained in leguminous plant seed - Google Patents

Angiotensinase activity inhibitor contained in leguminous plant seed

Info

Publication number
JPH04261122A
JPH04261122A JP3040511A JP4051191A JPH04261122A JP H04261122 A JPH04261122 A JP H04261122A JP 3040511 A JP3040511 A JP 3040511A JP 4051191 A JP4051191 A JP 4051191A JP H04261122 A JPH04261122 A JP H04261122A
Authority
JP
Japan
Prior art keywords
beans
angiotensin
converting enzyme
angiotensinase
soybeans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3040511A
Other languages
Japanese (ja)
Inventor
Takuya Hirose
琢也 広瀬
Masahiko Ikekita
雅彦 池北
Takamasa Yamaguchi
山口 高正
Hiroshi Moriya
守屋 寛
Haruhisa Hirata
晴久 平田
Yoshitami Ohashi
大橋 良民
Masakazu Ebie
正和 蛯江
Hatsunori Toyofuku
豊福 初則
Masayoshi Goto
正義 後藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Priority to JP3040511A priority Critical patent/JPH04261122A/en
Publication of JPH04261122A publication Critical patent/JPH04261122A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide the title inhibitor, an extract from leguminous plant seeds which gives hypotensive activity through angiotensinase inhibition. CONSTITUTION:The objective substance giving angiotensinase inhibitory activity can be obtained by purifying, using, e.g. ion exchange chromatography, an extract from seeds of leguminous plant(s) such as kidney beans, white beans, red beans, cowpeas, red peas, soybeans, black soybeans, etc. For the extract from each kind of the above seeds, the measurement of 50% inhibitory concentration for the angiotensinase of rabbit lung origin was 5-25mug/ml.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、豆科植物ファゼオラス
・ブルガリス(エル)〔Phaseolus vulg
aris(L).大正キントキ豆、白いんげん〕,ファ
ゼオラス・コクシネウス(エル)〔Phaseolus
 coccineus (L).とら豆,紫花豆,白花
豆〕,ファゼオラス・アンギュラリス.ダヴリュ.エフ
.ワイト〔Phaseolus angularis 
W.F.Wight,あずき〕,フィグナ・シネンシス
.エンドル〔Vigna sineusis Endl
.ささげ〕,ピスム・サチブム(エル)〔Pisum 
sativum (L),赤えんどう〕,グリシン・マ
ックス,メリル,〔Glycine max Merr
ill,くらかけ豆,がんくい豆,大豆,ひたし豆(青
大豆),黒豆,丹波大黒〕の種子部の水抽出物をイオン
交換クロマトグラフィーで精製したアンジオテンシン変
換酵素阻害活性を有する粗精製物に関する。
[Industrial Application Field] The present invention is directed to the leguminous plant Phaseolus vulgaris (L.).
aris(L). Taisho Kintoki Bean, White Bean], Phaseolus coccineus (L)
coccineus (L). Tiger bean, purple-flowered bean, white-flowered bean], Phaseolus angularis. D'Avryu. F. Wight [Phaseolus angularis]
W. F. Wight, Azuki], Figna sinensis. Vigna sineusis Endl
.. Cowpea], Pisum sativum (L.)
sativum (L), red pea], glycine max, Merr
A crude product with angiotensin-converting enzyme inhibitory activity purified by ion-exchange chromatography from the aqueous extract of the seeds of Ill, Kurakake beans, Gankui beans, soybeans, hitashi beans (green soybeans), black soybeans, and Tamba Daikoku. Regarding.

【0002】0002

【従来の技術】アンジオテンシン変換酵素は主として肺
、血管内皮細胞、腎近位尿細管等に存在し、アンジオテ
ンシンIに作用して、そのC末端よりジペプチドを切断
して強力な昇圧作用を有するアンジオテンシンIIに変
換する酵素である。また、この酵素は生体内の降圧物質
であるブラジキニンを破壊し、不活化する作用も有して
おり、二重に昇圧系に関与していることが知られている
。従来、このアンジオテンシン変換酵素の活性を阻害す
れば、降圧に働き、臨床的には、高血圧症の予防あるい
は治療に有効であると考えられている。
[Prior Art] Angiotensin-converting enzyme exists mainly in the lungs, vascular endothelial cells, renal proximal tubules, etc., and acts on angiotensin I to cleave a dipeptide from its C-terminus, resulting in angiotensin II, which has a strong pressor effect. It is an enzyme that converts This enzyme also has the effect of destroying and inactivating bradykinin, a hypotensive substance in living organisms, and is known to be doubly involved in the pressor system. It has been conventionally believed that inhibiting the activity of angiotensin-converting enzyme lowers blood pressure and is clinically effective in preventing or treating hypertension.

【0003】このような作業仮説のもとに医薬品として
開発されたのが、カプトプリルやエナラプリルである。 これらの薬剤は合成品である。一方天然に見出されるア
ンジオテンシン変換酵素阻害物質は極めて稀であり、わ
ずかにブラジル産や日本産の蛇毒より得られたアミノ酸
9個からなるペプチド物質(プロタイド,SQ2088
1)やストレプトマイセス属に属する放線菌の代謝産物
1583(特開昭58−177920号)が知られてい
るにすぎない。
Captopril and enalapril were developed as pharmaceuticals based on this working hypothesis. These drugs are synthetic. On the other hand, angiotensin-converting enzyme inhibitors found in nature are extremely rare, and only a peptide substance (Protide, SQ2088) consisting of 9 amino acids obtained from snake venom from Brazil and Japan.
1) and the metabolite 1583 of actinomycetes belonging to the genus Streptomyces (Japanese Unexamined Patent Publication No. 177920/1983) are only known.

【0004】また最近では、蛋白質をプロテアーゼ類で
処理して得られるアンジオテンシン変換酵素阻害物質と
して、牛乳カゼインをトリプシンにより分解して得られ
るペプチド類が知られているに過ぎない。(特開昭58
−10942号,同59−44323号,同59−44
324号,同61−36226号,同61−36227
号)。
[0004] Recently, only peptides obtained by decomposing milk casein with trypsin have been known as angiotensin converting enzyme inhibitors obtained by treating proteins with proteases. (Unexamined Japanese Patent Publication No. 58
-10942, 59-44323, 59-44
No. 324, No. 61-36226, No. 61-36227
issue).

【0005】[0005]

【発明が解決しようとする問題点】このような従来技術
の背景をもとに、本発明者らは、豆科植物の種子を、な
んら酵素処理をすることなく、天然のままに存在してい
るアンジオテンシン変換酵素阻害活性物質を探索したと
ころ、大正キントキ豆、白いんげん、とら豆、紫花豆、
白花豆、あずき、ささげ、赤えんどう、くらかけ豆、が
んくい豆、大豆、ひたし豆(青大豆)、黒豆、丹波大黒
等の水抽出物にアンジオテンシン変換酵素阻害活性を有
する物質が存在することを見出し、鋭意研究をした結果
、本発明完成をするに至った。
[Problems to be Solved by the Invention] Based on the background of the prior art, the present inventors have developed a method for producing seeds of leguminous plants in their natural state without any enzyme treatment. When we searched for angiotensin-converting enzyme inhibiting substances, we found Taisho Kintoki beans, white beans, tiger beans, purple flower beans,
Substances that have angiotensin-converting enzyme inhibitory activity are present in aqueous extracts of white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. As a result of this discovery and extensive research, we have completed the present invention.

【0006】すなわち、本発明は常用食品素材すなわち
種子中に含まれる有効成分であって、副作用が少く使用
し易く、通常の食物として摂取することも可能であり、
また有効成分のみを抽出精製すれば優れた医薬品として
提供できるものである。
[0006] That is, the present invention is an active ingredient contained in a commonly used food material, that is, seeds, which has few side effects, is easy to use, and can be ingested as a normal food.
Moreover, if only the active ingredients are extracted and purified, it can be provided as an excellent medicine.

【0007】[0007]

【発明の具体的説明】本発明者らはこのような技術水準
のもとに、天然有機化合物を広く検索し、副作用の少い
アンジオテンシン変換酵素阻害物質をもとめ鋭意研究し
た結果、常用食品素材であるマメ科植物種子の水抽出物
中に強いアンジオテンシン変換酵素阻害活性を見出し、
その活性成分は各種イオン交換クロマトグラフィーによ
り吸脱着できる性質があることを見出した。
[Detailed Description of the Invention] Based on the above-mentioned state of the art, the present inventors searched widely for natural organic compounds and conducted intensive research in search of an angiotensin-converting enzyme inhibitor with few side effects. We discovered strong angiotensin-converting enzyme inhibitory activity in the aqueous extract of certain legume seeds.
It was discovered that the active ingredient has the property of being able to be adsorbed and desorbed by various ion exchange chromatography methods.

【0008】一般に天然物からの活性成分の分離精製に
は活性成分のもつ物理化学的性質を利用して抽出精製を
行うのが常法である。
[0008] In general, the conventional method for separating and purifying active ingredients from natural products is to perform extraction and purification using the physicochemical properties of the active ingredients.

【0009】本発明は、まず、大正キントキ豆、白いん
げん、とら豆、紫花豆、白花豆、あずき、ささげ、赤え
んどう、くらかけ豆、がんくい豆、大豆、ひたし豆(青
大豆)、黒豆、丹波大黒等の豆類を各々、別々にミキサ
ーで粉砕し、一定量の粉砕物をノルマルヘキサン、石油
エーテル、クロロホルム等の水と分別できる有機溶媒に
浸し、充分混和して、各種豆類に含まれる、脂質成分を
除去することが可能である。
[0009] The present invention first uses Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans) Pulses such as , black soybeans, and Tamba Daikoku are ground separately in a mixer, and a certain amount of the ground material is immersed in an organic solvent that can be separated from water, such as n-hexane, petroleum ether, or chloroform, and thoroughly mixed to produce various beans. It is possible to remove the contained lipid components.

【0010】また、上記豆類から、除タンパクを行うた
めには、通常は水と混和できる溶剤、例えば、エタノー
ル、メタノール、アセトンなど、あるいは、無機塩類を
加えて、沈澱せしめる塩析法や、トリクロロ酢酸を加え
て沈澱物を取り除く方法など、通常行われているあらゆ
る除タンパクの方法が適用できる。
[0010] In addition, in order to remove protein from the above-mentioned legumes, usually a water-miscible solvent such as ethanol, methanol, acetone, etc., or a salting-out method in which precipitation is performed by adding inorganic salts, or trichloromethane are used. Any commonly used protein removal methods can be applied, such as adding acetic acid to remove precipitates.

【0011】このようにして脱脂質、脱タンパクを行っ
た各種豆科植物の種子の水抽出液のアンジオテンシン変
換酵素阻害活性をヒップリルーヒスチジル−ロイシン(
Hip−His−Leu)を基質に用い、クッシュマン
法(ディ−・ダヴリュ・クッシュマンらバイオケミカル
ファーマコロジー20巻、1637頁、1971年〔D
.W.Cushman etal,Biochem. 
Phamacol. 20,1637(1971)〕を
一部改変した方法で測定した結果、大正キントキ豆、白
いんげん、とら豆、紫花豆、白花豆、あずき、ささげ、
赤えんどう、くらかけ豆、がんくい豆、大豆、ひたし豆
(青大豆)黒豆、丹波大黒等のすべての豆種子中に強力
な阻害活性を認めた。
The angiotensin-converting enzyme inhibitory activity of the aqueous extracts of the seeds of various leguminous plants that have been delipidated and deproteinized in this manner was determined by hip-lyr-histidyl-leucine (
Hip-His-Leu) was used as a substrate, and the Cushman method (D.
.. W. Cushman et al., Biochem.
Pharmacol. 20, 1637 (1971)], the results were as follows: Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas,
Strong inhibitory activity was observed in all soybean seeds such as red peas, kurakake beans, gankui beans, soybeans, hitashi beans (green soybeans), black beans, and Tamba Daikoku.

【0012】さらに各種豆科植物の種子から得られた水
抽出液をイオン交換クロマトグラフィー、例えば、陽イ
オン交換樹脂としては、アンバーライトIR−120(
ロームアンドハース社製)ダウエックス50W(ダウケ
ミカル社製)、ダイヤイオンSK1A(三菱化成社製)
、また陰イオン交換樹脂として例えば、アンバーライト
IRA402,IRA68(ロームアンドハース社製)
、ダウエックス1(ダウケミカル社製)、ダイヤイオン
SA10B,PA−404,WA−30(三菱化成社製
)などを用いて吸着せしめ、塩、アルカリ、あるいは酸
を含む水溶液あるいは緩衝液などで容易に、本発明のア
ンジオテンシン変換酵素阻害剤が得られる。得られた分
画を前記クッシュマン法の一部改変した測定法で測定す
ると大正キントキ豆、白いんげん、とら豆、紫花豆、白
花豆、あずき、ささげ、赤えんどう、くらかけ豆、がん
くい豆、大豆、ひたし豆(青大豆)、黒豆、丹波大黒等
の水抽出物をそれぞれイオン交換クロマトグラフィーで
精製した各々の粗精製物に強い阻害活性を認めた。
Furthermore, aqueous extracts obtained from seeds of various leguminous plants are subjected to ion exchange chromatography, such as Amberlite IR-120 (as a cation exchange resin).
(manufactured by Rohm and Haas) DOWEX 50W (manufactured by Dow Chemical), Diaion SK1A (manufactured by Mitsubishi Kasei)
, and anion exchange resins such as Amberlite IRA402 and IRA68 (manufactured by Rohm and Haas)
, DOWEX 1 (manufactured by Dow Chemical Company), DIAION SA10B, PA-404, WA-30 (manufactured by Mitsubishi Chemical Corporation), etc., and easily adsorbed with an aqueous solution or buffer containing salt, alkali, or acid. In this way, the angiotensin converting enzyme inhibitor of the present invention is obtained. When the obtained fractions were measured using a partially modified measurement method of the above-mentioned Cushman method, Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, and ganku beans were detected. Strong inhibitory activity was observed in each of the crudely purified water extracts of beans, soybeans, hitashi beans (green soybeans), black soybeans, Tamba Daikoku, etc., each purified by ion exchange chromatography.

【0013】本発明によれば、大正キントキ豆、白いん
げん、とら豆、紫花豆、白花豆、あずき、ささげ、赤え
んどう、くらかけ豆、がんくい豆、大豆、ひたし豆(青
大豆)、黒豆、丹波大黒等の植物種子に特異的に含まれ
ているアンジオテンシン変換酵素阻害物質を、多量混在
している不純物から効率よく分別することができる。
According to the present invention, Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans) Angiotensin-converting enzyme inhibitors, which are specifically contained in plant seeds such as , black soybeans, and Tamba Daikoku, can be efficiently separated from impurities that are present in large quantities.

【0014】本発明のアンジオテンシン変換酵素阻害物
質はpH7.5において90℃、30分の熱処理に対し
安定であり、セロファン膜によって透析される。
The angiotensin-converting enzyme inhibitor of the present invention is stable to heat treatment at 90° C. for 30 minutes at pH 7.5, and is dialyzed through a cellophane membrane.

【0015】[0015]

【発明の効果】本発明の大正キントキ豆、白いんげん、
とら豆、紫花豆、白花豆、あずき、ささげ、赤えんどう
、くらかけ豆、がんくい豆、大豆、ひたし豆(青大豆)
、黒豆、丹波大黒等の豆科植物種子中より得られた水抽
出物およびイオン交換クロマトグラフィーで得られた粗
抽出物中には強力なアンジオテンシン変換酵素阻害活性
を示し、血圧降下作用、ブラジキニン不活化抑制作用を
示し、本態性高血圧、腎性高血圧、副腎性高血圧などの
高血圧症の予防、治療、これら疾患の診断薬や各種病態
において用いられる血圧降下剤として有用である。
[Effects of the invention] Taisho Kintoki beans, white beans,
Tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black peas, hard beans, soybeans, hitashi beans (green soybeans)
Aqueous extracts obtained from the seeds of leguminous plants such as black soybeans and Tamba Daikoku, and crude extracts obtained by ion-exchange chromatography, exhibit strong angiotensin-converting enzyme inhibitory activity and have antihypertensive effects and bradykinin inhibition. It exhibits an activation-suppressing effect and is useful for the prevention and treatment of hypertension such as essential hypertension, renal hypertension, and adrenal hypertension, as a diagnostic agent for these diseases, and as a hypotensive agent used in various pathological conditions.

【0016】一方、本発明は常用食品素材から抽出、精
製したものであって、通常の食品中に含まれる食品成分
であり、この点から観て、副作用等による影響は極めて
少ないものと予測される。
On the other hand, the present invention is extracted and purified from commonly used food materials, and is a food ingredient contained in common foods.From this point of view, it is expected that there will be very little influence from side effects. Ru.

【0017】したがって、本発明の水抽出物および粗精
製物は前記に示した血圧降下作用という重要な生理活性
を有しており、普通、食用としている豆科植物種子中に
食品のもつ機能特性が発揮されることを考え併せば、機
能性食品の重要な食品素材としても有用である。
[0017] Therefore, the aqueous extract and crudely purified product of the present invention have the important physiological activity of lowering blood pressure as shown above, and have the functional properties of food in leguminous plant seeds that are commonly eaten. Considering that it exhibits the following properties, it is also useful as an important food ingredient for functional foods.

【0018】以下に実施例を  掲記し本発明をさらに
詳細に説明する。
[0018] The present invention will be explained in more detail with reference to Examples below.

【0019】[0019]

【実施例】I.水抽出物の取得 市販の大正キントキ豆、白いんげん、とら豆、紫花豆、
白花豆、あずき、ささげ、赤えんどう、くらかけ豆、大
豆、ひたし豆(青大豆)、黒豆、丹波大黒等の種子各々
20gずつをミキサーで5分間粉砕し、30メッシュの
篩を通して各々の粉砕物を得た。
[Example] I. Obtaining water extracts Commercially available Taisho Kintoki beans, white beans, tiger beans, purple flower beans,
Grind 20g each of seeds such as white flower beans, azuki beans, cowpeas, red peas, black beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. for 5 minutes with a mixer, and pass through a 30-mesh sieve. I got something.

【0020】各々の粉砕物にそれぞれ8mlのノルマル
ヘキサンを加え1時間撹拌してノルマルヘキサンを濾別
した。再び8mlのノルマルヘキサンをそれぞれに加え
同様の操作を行った。それぞれの残渣を風乾し、脱脂し
た風乾物を得た。
8 ml of n-hexane was added to each of the pulverized products and stirred for 1 hour, and the n-hexane was filtered off. Again, 8 ml of n-hexane was added to each and the same operation was performed. Each residue was air-dried to obtain a defatted air-dried product.

【0021】上記それぞれの風乾物に8mlの水を加え
、よく混和すると黄褐色から黄色の粘稠な液が得られ、
これらの液に8mlのエタノールを加えて、再びよく混
和すると不溶部分と白色沈殿物が生じた。生じた沈殿物
を10,000r.p.m.20分間遠心分離を行いそ
れぞれ粘性のない上澄液約14mlずつを得た。このよ
うにして得られた上澄液を40℃で減圧濃縮後、凍結乾
燥をして下記に示したそれぞれの水抽出物を得た。(第
1表)これらの水抽出物についてアンジオテンシン変換
酵素阻害活性を調べた。
Add 8 ml of water to each of the above air-dried products and mix well to obtain a yellowish brown to yellow viscous liquid.
When 8 ml of ethanol was added to these solutions and mixed well again, an insoluble portion and a white precipitate were generated. The resulting precipitate was heated to 10,000r. p. m. Centrifugation was performed for 20 minutes to obtain approximately 14 ml of non-viscous supernatant liquid. The supernatant thus obtained was concentrated under reduced pressure at 40° C. and then freeze-dried to obtain the respective aqueous extracts shown below. (Table 1) These aqueous extracts were examined for angiotensin converting enzyme inhibitory activity.

【0022】[0022]

【表1】 II. 粗精製物の取得 大正キントン豆、白いんげん、とら豆、紫花豆、白花豆
、あずき、ささげ、赤えんどう、くらかけ豆、大豆、ひ
たし豆(青大豆)、黒豆、丹波大黒等の水抽出物2gを
水20mlにそれぞれ溶解し、IN塩酸でpH5.0に
調整後、アンバーライトIR−120(H+ 型)のイ
オン交換カラムクロマト(カラム:直径1.5cm×高
さ10cm)に通液し吸着後、30mlの水で充分水洗
し、次いで0.3Nのアンモニヤ水50mlで溶出した
[Table 1] II. Acquisition of crude refined products Water extraction of Taisho Kinton beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, kurakake beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. Dissolve 2 g of each in 20 ml of water, adjust the pH to 5.0 with IN hydrochloric acid, and pass through an ion exchange column chromatograph (column: diameter 1.5 cm x height 10 cm) of Amberlite IR-120 (H+ type). After adsorption, the mixture was thoroughly washed with 30 ml of water, and then eluted with 50 ml of 0.3N aqueous ammonia.

【0023】それぞれの溶出液を減圧F40℃でアンモ
ニヤを回収後、凍結乾燥して、第2表に示したそれぞれ
の粗精製物を得た。
[0023] After recovering ammonia from each eluate under reduced pressure at F40°C, it was freeze-dried to obtain each crude product shown in Table 2.

【0024】これらの粗精製物についてアンジオテンシ
ン変換酵素阻害活性を調べた。
[0024] These crude products were examined for angiotensin converting enzyme inhibitory activity.

【0025】[0025]

【表2】 III.アンジオテンシン変換酵素阻害活性の測定実験
材料(1)アンジオテンシン変換酵素:ウサギ肺のアン
ジオテンシン変換酵素をシグマ化学社より購入(2)ア
ンジオテンシン変換酵素阻害物質前記実施例I,II項
で得られた26検体 (3)酵素基質
[Table 2] III. Experimental materials for measuring angiotensin-converting enzyme inhibitory activity (1) Angiotensin-converting enzyme: rabbit lung angiotensin-converting enzyme purchased from Sigma Chemical Co., Ltd. (2) Angiotensin-converting enzyme inhibitor 26 samples obtained in Examples I and II above ( 3) Enzyme substrate

【0026】[0026]

【化1】 IV. アンジオテンシン変換酵素阻害活性の測定。[Chemical formula 1] IV. Measurement of angiotensin converting enzyme inhibitory activity.

【0027】アンジオテンシン変換酵素阻害活性の測定
法は各々の検体の存在下と、検体の非存在下におけるア
ンジオテンシン変換酵素の酵素活性を測定し、これと求
められた阻害率から各検体の阻害活性IC50を算出し
た。
The method for measuring angiotensin converting enzyme inhibitory activity is to measure the enzyme activity of angiotensin converting enzyme in the presence and absence of each specimen, and from this and the determined inhibition rate, the inhibitory activity IC50 of each specimen is determined. was calculated.

【0028】なお、アンジオテンシン変換酵素活性の測
定は、前記クッシュマンの方法に従い、さらにハヤカリ
らの変法〔アナリティカルバイオケミストリー84巻、
361頁1978年;Anal.Biochem. 8
4,361(1978)〕を採用して以下のごとくに行
った。
[0028] The angiotensin converting enzyme activity was measured according to the method of Cushman and a modified method of Hayakari et al. [Analytical Biochemistry Vol. 84,
361 pages 1978; Anal. Biochem. 8
4,361 (1978)] was adopted as follows.

【0029】すなわち50mMのトリス塩酸緩衝液(p
H8.2)、0.3Mの塩化ナトリウム水溶液、2mM
のHip−His−Leu の基質、ウサギの肺由来の
アンジオテンシン変換酵素(1〜2ミリユニット)およ
び、各検体を含む酵素反応液250μl を37℃30
分間インキュベートした。
That is, 50mM Tris-HCl buffer (p
H8.2), 0.3M sodium chloride aqueous solution, 2mM
250 μl of enzyme reaction solution containing Hip-His-Leu substrate, rabbit lung-derived angiotensin converting enzyme (1-2 milliunits), and each sample was heated at 37°C.
Incubated for minutes.

【0030】次いで、IN水酸化ナトリウム水溶液15
μl を加えて反応を停止し、室温にて、30分間放置
後、60mMのリン酸ナトリウム緩衝液(pH7.2)
1mlと1%シアヌール酸クロライドを含むメチルセロ
ソルブ1mlを加えて、15分間放置後382nmの吸
光度を測定した。
Next, IN sodium hydroxide aqueous solution 15
The reaction was stopped by adding μl of 60mM sodium phosphate buffer (pH 7.2) and left at room temperature for 30 minutes.
1 ml of methyl cellosolve containing 1% cyanuric acid chloride was added thereto, and after being left for 15 minutes, the absorbance at 382 nm was measured.

【0031】各々の検体を含む反応液の吸光度(a)と
検体を含まない吸光度(b)と、それぞれに対する反応
しない盲検の吸光度(a´およびb´)から阻害率を次
式により求めた。
[0031] The inhibition rate was calculated from the absorbance of the reaction solution containing each sample (a), the absorbance without the sample (b), and the absorbance of a blind sample that did not react to each (a' and b') using the following formula. .

【0032】[0032]

【数1】 上記測定法にもとずき、検体のいくつかの濃度における
阻害率を求め、50%阻害濃度(IC50)を算出した
[Equation 1] Based on the above measurement method, the inhibition rate at several concentrations of the specimen was determined, and the 50% inhibitory concentration (IC50) was calculated.

【0033】V.実験結果、本発明の大正キントキ豆、
白いんげん、とら豆、紫花豆、白花豆、あずき、ささげ
、赤えんどう、くらかけ豆、がんくい豆、大豆、ひたし
豆(青大豆)、黒豆、丹波大黒由来の各々の水抽出物及
び各々の粗精製物のアンジオテンシン変換酵素に対する
阻害活性は第3表に示すとおりであり、実施例で工程I
において得られた抽出物に対して10〜13倍の活性上
昇が認められた。
[0033]V. Experimental results show that the Taisho Kintoki beans of the present invention,
Each water extract derived from white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, kurakake beans, hard beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku and The inhibitory activity of each crude product against angiotensin converting enzyme is as shown in Table 3.
A 10- to 13-fold increase in activity was observed compared to the extract obtained in .

【0034】[0034]

【表3】[Table 3]

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】  アンジオテンシン変換酵素阻害活性を
有する豆科植物である、ファゼオラス  ブルガリス(
エル)、ファゼオラス  コクシネウス(エル)、ファ
ゼオラス  アンギュラリス  ダヴリュ.エフ.ワイ
ト、フィグナ  シネンシス.エンドル、ピスム  サ
チブム(エル)、グリシン  マックス  メリルの種
子からの水抽出物。
Claim 1: Phaseolus vulgaris, a leguminous plant that has angiotensin-converting enzyme inhibitory activity.
(L), Phaseolus coccineus (L), Phaseolus angularis (L). F. Wight, Figna sinensis. Aqueous extract from seeds of Endor, Pisum sativum (L.), Glycine max meryl.
【請求項2】  前記各々の豆種子の水抽出物を有機溶
媒により脂質脂肪酸などの不純物を除去し、次いでイオ
ン交換クロマトグラフィーで精製されることを特徴とす
る特許請求の第1項記載のアンジオテンシン変換酵素阻
害活性を有する物質、即ち、アンジオテンシン変換酵素
降圧剤及びその製法。
2. The angiotensin according to claim 1, wherein impurities such as lipids and fatty acids are removed from the aqueous extract of each bean seed using an organic solvent, and then purified by ion exchange chromatography. A substance having converting enzyme inhibitory activity, that is, an angiotensin converting enzyme antihypertensive agent, and a method for producing the same.
JP3040511A 1991-02-13 1991-02-13 Angiotensinase activity inhibitor contained in leguminous plant seed Pending JPH04261122A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3040511A JPH04261122A (en) 1991-02-13 1991-02-13 Angiotensinase activity inhibitor contained in leguminous plant seed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3040511A JPH04261122A (en) 1991-02-13 1991-02-13 Angiotensinase activity inhibitor contained in leguminous plant seed

Publications (1)

Publication Number Publication Date
JPH04261122A true JPH04261122A (en) 1992-09-17

Family

ID=12582570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3040511A Pending JPH04261122A (en) 1991-02-13 1991-02-13 Angiotensinase activity inhibitor contained in leguminous plant seed

Country Status (1)

Country Link
JP (1) JPH04261122A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549432A (en) * 1991-08-23 1993-03-02 Takano Co Ltd Food additive
US6949263B2 (en) * 2000-12-11 2005-09-27 Kikkoman Corporation Method for preparing nicotianamine or nicotianamine-containing product
JP2010053125A (en) * 2008-07-28 2010-03-11 Nisshin Pharma Inc Anti-allergic agent
JP2010229069A (en) * 2009-03-26 2010-10-14 Aomori Univ Of Health & Welfare Agent for preventing and ameliorating arteriosclerosis and method for preventing arteriosclerosis
WO2011080825A1 (en) * 2009-12-28 2011-07-07 日清ファルマ株式会社 Anti-allergic agent

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549432A (en) * 1991-08-23 1993-03-02 Takano Co Ltd Food additive
JP2505330B2 (en) * 1991-08-23 1996-06-05 タカノ株式会社 Food additive
US6949263B2 (en) * 2000-12-11 2005-09-27 Kikkoman Corporation Method for preparing nicotianamine or nicotianamine-containing product
JP2010053125A (en) * 2008-07-28 2010-03-11 Nisshin Pharma Inc Anti-allergic agent
JP2010229069A (en) * 2009-03-26 2010-10-14 Aomori Univ Of Health & Welfare Agent for preventing and ameliorating arteriosclerosis and method for preventing arteriosclerosis
WO2011080825A1 (en) * 2009-12-28 2011-07-07 日清ファルマ株式会社 Anti-allergic agent
CN102711782A (en) * 2009-12-28 2012-10-03 日清药业股份有限公司 Anti-allergic agent

Similar Documents

Publication Publication Date Title
EP2145630B1 (en) Angiotensin-converting enzyme inhibitory peptides
Wang et al. Isolation and identification of a novel peptide from zein with antioxidant and antihypertensive activities
KR20060118395A (en) Casein hydrolyzate, process for producing the same and use thereof
JPH04261122A (en) Angiotensinase activity inhibitor contained in leguminous plant seed
KR20150036167A (en) Angiotensin-converting-enzyme inhibiting dipeptide
JP4790325B2 (en) Antihypertensive peptide derived from meat protein
JPH06256387A (en) New peptide, its production and hypotensive agent comprising the same as active ingredient
Yu et al. Preparation and function of oligopeptide-enriched hydrolysate from globin by pepsin
JP2002088098A (en) Pearl oyster-originating ace-inhibitory peptide
JP3651878B2 (en) Antihypertensive peptide derived from meat protein
JP2873327B2 (en) Angiotensin converting enzyme inhibitor
JP3406341B2 (en) New peptides, their production methods and applications
KR100295739B1 (en) Angiotensin I Converting Enzyme Inhibitor
JP3401280B2 (en) New peptides, their production methods and applications
Aoyagi et al. Constituents of a cationic peptide-rich fraction of Lentinus edodes
KR100367782B1 (en) Preperation of peptide from laver having inhibitory activity against angiotensin converting enzyme
KR0150798B1 (en) Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides
JPH01313498A (en) Novel peptide &m:a peptide of the formula.
JPH04164094A (en) New peptide, its production and angiotensin converting enzyme inhibitor containing the same peptide as active ingredient
JPH04139196A (en) New peptide, its production and use thereof
EP2548458B1 (en) Lupin-derived compounds having hypotensive activity and process for their production
JPH07313185A (en) Production of peptide
JPH02282394A (en) New peptide and hypotensive agent
Bauer et al. Novel microbial inhibitors of ACE* Isolation and characterization
KR20050027239A (en) Process for obtaining serine proteinase inhibitor from canavalia gladiata